Chargement en cours...
PEGylated drugs in rheumatology—why develop them and do they work?
Lack of efficacy and drug-related adverse effects are important reasons for the discontinuation of treatment in patients with rheumatic diseases. The development of new biologic therapies seeks to address these problems by specifically targeting the pathogenic mechanisms of disease. Most current bio...
Enregistré dans:
| Auteurs principaux: | , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Oxford University Press
2014
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3930883/ https://ncbi.nlm.nih.gov/pubmed/23962623 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/rheumatology/ket278 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|